Asensus Surgical Secures FDA 510(k) Clearance For Pediatric Indication For Senhance Surgical System
The Senhance System is already approved for pediatric patients in the EU and Japan.
Pharvaris Phase 2 Data From RAPIDe-1 Study Of PHVS416 For The On-Demand Treatment Of Hereditary Angioedema Attacks Highlighted At The 2023 HAEi Regional Conference APAC On Saturday, March 18
Pharvaris (NASDAQ:PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced an oral presentation of positive
Sarepta Therapeutics’ FDA Adcomm Puts Some Risk, With Potential Approval: Analyst
Thursday afternoon, the FDA announced holding an advisory committee meeting related to Sarepta Therapeutics Inc’s (NASDAQ:SRPT) SRP-9001 (delandistrogene moxeparvovec) marketing application.…
FDA Advisory Committee Votes Favoring Pfizer’s COVID-19 Pill Paxlovid
The FDA’s Antimicrobial Drugs Advisory Committee voted 16-1 that available data support the safety and effectiveness of Pfizer Inc’s (NYSE:PFE) Paxlovid for…
FDA Approves Novartis’ Tafinlar + Mekinist For Pediatric Brain Cancer With Certain Mutations
The FDA has approved Novartis AG’s (NYSE:NVS) Tafinlar (dabrafenib) + Mekinist (trametinib) for pediatric patients one year of age and older…
Catalent And BHAMI Research Laboratory Enter Into Licensing Agreement For Technology To Deliver High-Concentration Biologics Subcutaneously
https://www.catalent.com/catalent-news/catalent-and-bhami-research-laboratory-enter-into-licensing-agreement/
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
Three companies have provided updates on their efforts to assess different psychedelics for treating a widely varied set of conditions.
Silo Pharma Announces Results From IND-Enabling Study Of SP-26 For Fibromyalgia; Shares Move Higher
Silo Pharma, Inc. (NASDAQ:SILO) ("the Company"), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has achieved